Clinical Trials Browser

Interventional × Esophageal Squamous Cell Carcinoma × CP protocol × Clear all

Esophageal Squamous Cell Carcinoma

NCT02658214 2020-08-20

Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors

BreastGastrointestinalGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms, Carcinoma, Pancreatic Ductal, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT03940001 2019-09-09

A Study of Sintilimab Plus Chemoradiation Before Surgery for Esophageal Cancer

Phase EARLY_PHASE1 Unknown

20 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma

Clinical Trials

NEEDS

Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors

A Study of Sintilimab Plus Chemoradiation Before Surgery for Esophageal Cancer